Umeclidinium bromide/vilanterol
Umeclidinium bromide/vilanterol (trade name Anoro Ellipta) is a combination drug approved for the treatment of chronic obstructive pulmonary disease (COPD).[1][2] It is applied as an inhalation.
 Umeclidinium bromide (TOP), vilanterol (BOTTOM) | |
| Combination of | |
|---|---|
| Umeclidinium bromide | Muscarinic antagonist |
| Vilanterol | Ultra-long-acting β2 agonist |
| Clinical data | |
| Trade names | Anoro Ellipta |
| AHFS/Drugs.com | anoro-ellipta |
| License data | |
| Pregnancy category |
|
| Routes of administration | Inhalation (DPI) |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| KEGG | |
References
- Feldman, GJ; Edin, A (2013). "The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: Current evidence and future prospects". Therapeutic advances in respiratory disease. 7 (6): 311–9. doi:10.1177/1753465813499789. PMID 24004659.
- "FDA Approves Umeclidinium and Vilanterol Combo for COPD". Medscape. December 18, 2013.
| Adrenergics, inhalants |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Glucocorticoids | |||||||||
| Anticholinergics/ muscarinic antagonist | |||||||||
| Mast cell stabilizers | |||||||||
| Xanthines | |||||||||
| Eicosanoid inhibition |
| ||||||||
| Others/unknown | |||||||||
| Combination products | |||||||||
| |||||||||
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.